Cargando…
The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
The tumor microenvironment exhibits altered metabolic properties as a consequence of the needs of tumor cells, the natural selection of the most adapted clones, and the selfish relationship with other cell types. Beyond its role in supporting uncontrolled tumor growth, through energy and building ma...
Autores principales: | Cruz-Bermúdez, Alberto, Laza-Briviesca, Raquel, Casarrubios, Marta, Sierra-Rodero, Belén, Provencio, Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067102/ https://www.ncbi.nlm.nih.gov/pubmed/33807260 http://dx.doi.org/10.3390/biomedicines9040361 |
Ejemplares similares
-
KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor
por: Serna-Blasco, R., et al.
Publicado: (2021) -
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2017) -
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
por: Sierra-Rodero, Belén, et al.
Publicado: (2021) -
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial
por: Laza‐Briviesca, Raquel, et al.
Publicado: (2021) -
ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib
por: Romero, Atocha, et al.
Publicado: (2020)